zinc oxide has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Froelich, K; Ginzkey, C; Hackenberg, S; Hagen, R; Harnisch, W; Kleinsasser, N; Koehler, C; Scherzed, A | 1 |
| Basu, R; Brunt, KR; Das, SK; Fisher, PB; Konar, S; Kumar, BNP; Mandal, M; Mazumdar, A; Pathak, A; Puvvada, N; Rajput, S; Rao, RR; Sarkar, S | 1 |
| Akbarian, M; Elahi, SM; Mahjoub, S; Tashakkorian, H; Zabihi, E | 1 |
3 other study(ies) available for zinc oxide and paclitaxel
| Article | Year |
|---|---|
Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Catalysis; Cell Line, Tumor; Cisplatin; Drug Synergism; Humans; Metal Nanoparticles; Mouth Neoplasms; Necrosis; Paclitaxel; Ultraviolet Rays; Zinc Oxide | 2012 |
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Progression; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Paclitaxel; Transplantation, Heterologous; Zinc Oxide | 2015 |
Green synthesis, formulation and biological evaluation of a novel ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Nanoparticles; Paclitaxel; Particle Size; Surface Properties; Zinc Oxide | 2020 |